Increase in diazepam binding inhibitor-like immunoreactivity(51–70) in Huntington's disease
- 30 November 1988
- journal article
- research article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 88 (1-3) , 177-184
- https://doi.org/10.1016/0022-510x(88)90215-8
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Octadecaneuropeptide, benzodiazepine ligand, -like immunoreactivity in rat central nervous system, plasma and peripheral tissuesNeuroscience Letters, 1986
- Selective Sparing of a Class of Striatal Neurons in Huntington's DiseaseScience, 1985
- Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington's diseaseBrain Research, 1985
- Diazepam-Binding Inhibitor: A Neuropeptide Located in Selected Neuronal Populations of Rat BrainScience, 1985
- Neuropeptide modulation of GABA receptor Cl− channelsRegulatory Peptides, 1985
- On a brain polypeptide functioning as a putative effector for the recognition sites of benzodiazepine and beta-carboline derivativesNeuropharmacology, 1983
- Somatostatin is increased in the basal ganglia in Huntington diseaseAnnals of Neurology, 1983
- Regional distribution of methionine-enkephalin and substance P-like immunoreactivity in normal human brain and in Huntington's diseaseBrain Research, 1980
- The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent. Application to the radioimmunoassayBiochemical Journal, 1973
- REDUCED GLUTAMIC-ACID- DECARBOXYLASE ACTIVITY OF POST-MORTEM BRAIN IN HUNTINGTON'S CHOREAThe Lancet, 1973